Results 201 to 210 of about 274,619 (381)

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen   +7 more
wiley   +1 more source

Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy [PDF]

open access: bronze, 1978
C. Gropp   +2 more
openalex   +1 more source

Implementation of guidelines for intravenous iron therapy in heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital. Methods and results Patients with left ventricular ejection fraction (LVEF) < 50% and New York Heart Association (NYHA) class II–IV who visited ...
Milou Gamage   +5 more
wiley   +1 more source

Pulmonary congestion relief by adding dapagliflozin to intravenous loop diuretic in acute heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF). Methods and results A single‐centre open‐label clinical research study enrolled 98 patients admitted with an ...
Daniela Mocan   +7 more
wiley   +1 more source

Clinical characteristics and outcomes of adults with acute heart failure in a South African teaching hospital

open access: yesESC Heart Failure, EarlyView.
In this study of 406 adults admitted with acute heart failure, the overall in‐hospital mortality rate was 3.4%. Independent predictors of in‐hospital mortality included elevated neutrophil‐lymphocyte ratio, C‐reactive protein, and potassium levels, along with moderate or severe aortic regurgitation and lower diastolic blood pressure.
Umar G. Adamu   +2 more
wiley   +1 more source

The purification and properties of ferritin from human serum [PDF]

open access: green, 1976
Mark Worwood   +3 more
openalex   +1 more source

The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

open access: yesEuropean Journal of Heart Failure, EarlyView.
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy